CALCA and cancer: CGRP secreted from peripheral nerve terminals exerts a paracrine action on oral squamous carcinoma cells, and it has been suggested that, in this disease, CGRP is a bridge target between cancer-associated pain and cancer development because CGRP promotes the algesia transmission to pain centers [225].